The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetes
Andreas Höhn*, Anita Jeyam, Thomas M. Caparrotta, Stuart J. McGurnaghan, Joseph E. O’Reilly, Luke A. K. Blackbourn, Rory J. McCrimmon, Graham P. Leese, John A. McKnight, Brian Kennon, Robert S. Lindsay, Naveed Sattar, Sarah H. Wild, Paul M. McKeigue, Helen M. Colhoun
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetes'. Together they form a unique fingerprint.